心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688016 心脉医疗

已收盘 12-23 15:00:00

{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":116.27,"timestamp":1734937200000,"preClose":118.29,"halted":0,"volume":1619462,"delay":0,"floatShares":123000000,"shares":123000000,"eps":5.3329,"marketStatus":"已收盘","marketStatusCode":5,"change":-2.02,"latestTime":"12-23 15:00:00","open":117.8,"high":119.24,"low":116.25,"amount":190000000,"amplitude":0.0253,"askPrice":116.29,"askSize":25,"bidPrice":116.27,"bidSize":162,"shortable":0,"etf":0,"ttmEps":5.3329,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"adjPreClose":118.29,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":130.12,"lowLimit":106.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":123262117,"pbRate":3.69,"roa":"--","roe":"14.38%","epsLYR":6.81,"committee":-0.004274,"marketValue":14332000000,"floatMarketCap":14332000000,"peRate":21.802396,"changeRate":-0.0171,"turnoverRate":0.0131,"status":1,"afterMarket":{"amount":0,"volume":0,"close":116.27,"buyVolume":0,"sellVolume":0,"time":1734939238975,"indexStatus":"已收盘 12-23 15:30:00","preClose":118.29}},"requestUrl":"/m/hq/s/688016/wiki","defaultTab":"wiki","newsList":[{"id":"2493940972","title":"心脉医疗获融资买入0.43亿元，近三日累计买入0.95亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493940972","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493940972?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:03","pubTimestamp":1734739394,"startTime":"0","endTime":"0","summary":"12月20日，沪深两融数据显示，心脉医疗获融资买入额0.43亿元，居两市第354位，当日融资偿还额0.79亿元，净卖出3643.51万元。最近三个交易日，18日-20日，心脉医疗分别获融资买入0.29亿元、0.23亿元、0.43亿元。融券方面，当日融券卖出0.22万股，净卖出0.22万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221080737a1ff1051&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221080737a1ff1051&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2492450533","title":"心脉医疗涨5% 产品报价大降","url":"https://stock-news.laohu8.com/highlight/detail?id=2492450533","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492450533?lang=zh_cn&edition=full","pubTime":"2024-12-20 10:07","pubTimestamp":1734660450,"startTime":"0","endTime":"0","summary":"12月20日，心脉医疗股价大幅上涨，截至10点07分，心脉医疗上涨5.19%，报119.28元/股，成交1.26亿元，换手率0.88%，振幅5.54%。消息解读在第五批高值耗材国采申报信息公开现场，国产企业心脉医疗和先健科技成功通过二次报价将所有产品“复活”。其中，心脉医疗的下肢动脉支架和非下肢动脉支架二次降价幅度接近50%。最新财报显示，今年三季报，心脉医疗实现营业收入9.70亿元，同比增长9.13%，净利润为5.53亿元，同比增长42.46%，基本每股收益为4.49元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220100749984ce595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220100749984ce595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2492110675","title":"科利耳、波科、心脉医疗品种在第五批耗材国采中成功“复活”中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2492110675","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492110675?lang=zh_cn&edition=full","pubTime":"2024-12-19 12:54","pubTimestamp":1734584041,"startTime":"0","endTime":"0","summary":"格隆汇12月19日｜据财联社，在第五批高值耗材国采申报信息公开现场获悉，在二次报价结果中，人工耳蜗厂商科利耳和诺尔康通过降价“复活”，成功中选，这也意味着此次人工耳蜗集采的五家企业全部获得拟中选资格。在外周血管支架品类中，外企波科和巴德通过成功“复活”部分品类，从而实现三款产品全部拟中选。国产企业心脉医疗和先健科技也成功通过二次报价将所有产品“复活”，其中心脉医疗的下肢动脉支架和非下肢动脉支架二次降价幅度接近50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219125411ab838f8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219125411ab838f8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2492997225","title":"心脉医疗最新公告：控股子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492997225","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492997225?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:58","pubTimestamp":1734512312,"startTime":"0","endTime":"0","summary":"心脉医疗公告，公司控股子公司上海蓝脉医疗科技有限公司获得国家药品监督管理局颁发的医疗器械注册证，产品名称为外周球囊扩张导管，注册证编号为国械注准20243032576，有效期为2024年12月16日至2029年12月15日，注册分类为III类。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800028713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1583","BK1100","688016","159883","BK0251","BK1222","BK1574","09997"],"gpt_icon":0},{"id":"2492087329","title":"心脉医疗：控股子公司取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492087329","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492087329?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:56","pubTimestamp":1734512202,"startTime":"0","endTime":"0","summary":"每经AI快讯，心脉医疗12月18日晚间发布公告称，近日，上海微创心脉医疗科技（集团）股份有限公司的控股子公司上海蓝脉医疗科技有限公司获得国家药品监督管理局颁发的关于的医疗器械注册证。产品名称为“外周球囊扩张导管”。心脉医疗的董事长是Jonathan Chen，男，49岁，学历背景为本科；总经理是朱清，男，43岁，学历背景为硕士。每经头条（nbdtoutiao）——俄罗斯商品馆爆火，品牌方称利润率可达65%！有城市一个月新开73家，业内人士：有真货也有假货，明年会大面积地“死”(记者 王晓波)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218165737ab8160be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218165737ab8160be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159883","BK0251","688016"],"gpt_icon":0},{"id":"2492974538","title":"心脉医疗(688016.SH)子公司获得外周球囊扩张导管医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492974538","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492974538?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:47","pubTimestamp":1734511668,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心脉医疗(688016.SH)发布公告，近日，公司的控股子公司上海蓝脉医疗科技有限公司获得国家药品监督管理局颁发的关于外周球囊扩张导管的医疗器械注册证，该产品适用于外周血管系统，包括髂动脉和髂股静脉的经皮腔内血管成形术以及用于自体或人工动静脉透析瘘的阻塞性病变的治疗，该产品同样适用于支架和覆膜支架在上述外周血管中的术后扩张。上述产品医疗器械注册证的获得，进一步丰富了公司现有产品种类，扩充公司在外周静脉领域的产品线布局，进一步推动公司在外周领域的市场拓展，不断满足市场需求，促使公司整体销售收入以及利润稳步增长，进一步加深公司在主动脉及外周血管介入市场的影响力及竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688016","09997","159883","BK1583","BK1574","BK1222","BK1100","09996","BK0251"],"gpt_icon":0},{"id":"2491301583","title":"心脉医疗累计回购124万股 股份比例达1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491301583","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491301583?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:51","pubTimestamp":1734079860,"startTime":"0","endTime":"0","summary":"根据公告，公司通过集中竞价交易方式已累计回购股份124万股，占公司总股本比例为1%，与上次披露相比增加0.12%。第二期回购方案累计回购15万股，支付资金总额为1681万元，回购价格区间为109.264元/股至118.638元/股。第二期回购方案于2024年10月30日披露，预计回购金额为1亿元至2亿元，实施期限为2024年10月28日至2025年10月27日。2024年前三季度，心脉医疗实现收入9.70亿元，归母净利润5.53亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213165254a1eb7e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213165254a1eb7e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2491533301","title":"深度 | 误失高新资质补税风波尚未平息，心脉医疗又推低门槛激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2491533301","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491533301?lang=zh_cn&edition=full","pubTime":"2024-12-13 09:54","pubTimestamp":1734054882,"startTime":"0","endTime":"0","summary":"在历史低位附近，心脉医疗推出金额不菲的员工持股计划。心脉医疗12月9日发布公告称，将于12月24日召开股东大会，审议《2024年员工持股计划》等议案。此前12月4日晚发布的草案显示，本员工持股计划拟持有的标的股票数量约110 万股，约占股本总额的0.9%，参加对象包括公司董监高、核心人员及业务、技术骨干，总人数不超过187人，其中董监高共7人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213100914a1ea9e7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213100914a1ea9e7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2490573005","title":"上海设立百亿级生物医药产业并购基金！昊海生科、心脉医疗等本地股大涨5%！医疗ETF（512170）震荡飘红","url":"https://stock-news.laohu8.com/highlight/detail?id=2490573005","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490573005?lang=zh_cn&edition=full","pubTime":"2024-12-11 10:56","pubTimestamp":1733885760,"startTime":"0","endTime":"0","summary":"12月11日早盘，医疗板块继续活跃，上海本地医疗股多股走强，心脉医疗、昊海生科涨超5%！医美、民营医院龙头股也有表现，爱美客、美年健康涨超2%。下跌方面，迈瑞医疗、惠泰医疗等权重耗材股走低。　　行业主题ETF方面，逾260亿体量医疗ETF低开后拉升翻红，成交额超2亿元。　　方案明确：“设立100亿元生物医药产业并购基金”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-12-11/doc-incyzzcx0980680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688016","161726","512170","159828","399441","BK0239","688366"],"gpt_icon":0},{"id":"2490867587","title":"心脉医疗创近2月新高获增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490867587","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490867587?lang=zh_cn&edition=full","pubTime":"2024-12-11 10:07","pubTimestamp":1733882879,"startTime":"0","endTime":"0","summary":"12月11日，心脉医疗股价大幅上涨，截至10点07分，心脉医疗上涨5.04%，报116.74元/股，创近2个月新高，成交2.29亿元，换手率1.62%，振幅5.54%。资金动向截止发稿，心脉医疗获得主力净流入1109万元，其中超大单流入44万元，大单流入1065万元。最新财报显示，今年三季报，心脉医疗实现营业收入9.70亿元，同比增长9.13%，净利润为5.53亿元，同比增长42.46%，基本每股收益为4.49元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211100814ab6e35c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211100814ab6e35c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2490129927","title":"心脉医疗12月09日主力资金流出699万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490129927","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490129927?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:20","pubTimestamp":1733728833,"startTime":"0","endTime":"0","summary":"12月09日, 心脉医疗股价跌1.40%，报收109.48元，成交金额2.00亿元，换手率1.47%，振幅3.58%，量比0.44。心脉医疗今日主力资金净流出699万元，连续7日净流出，上一交易日主力净流出3519万元，今日环比减少80.14%。该股近5个交易日上涨3.14%，主力资金累计净流出1.83亿元；近20日主力资金累计净流出3.06亿元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209153808ab692a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209153808ab692a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2489473785","title":"揭开明星械企“管理能力”的盖子","url":"https://stock-news.laohu8.com/highlight/detail?id=2489473785","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489473785?lang=zh_cn&edition=full","pubTime":"2024-12-08 14:05","pubTimestamp":1733637908,"startTime":"0","endTime":"0","summary":"/ 01/ 被遗忘的报表继8月份收到医保局的公开问询后，心脉医疗再次收到来自监管部门的“问候”。对这笔税款及滞纳金，心脉医疗表示将予以补缴。与此同时，心脉医疗也表示，10月12日，上海市高新技术企业认定办公室发布《关于公示2024年上海市第二批拟认定高新技术企业名单的通知》，公司名列其中。这关乎组织文化和管理体系的调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241208140535a1dd31a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241208140535a1dd31a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2489291258","title":"心脉医疗12月06日收涨0.95% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2489291258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489291258?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:19","pubTimestamp":1733469572,"startTime":"0","endTime":"0","summary":"12月06日, 心脉医疗股价涨0.95%，报收111.03元，成交金额4.22亿元，换手率3.09%，振幅3.60%，量比1.02。心脉医疗今日主力资金净流出3519万元，连续6日净流出，上一交易日主力净流出1.06亿元，今日环比减少66.70%。近一年数据显示，该股主力连续6日净流出后，次日下跌概率为33.33%，平均跌幅为2.33%。该股近5个交易日上涨5.38%，主力资金累计净流出1.95亿元；近20日主力资金累计净流出2.94亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153045ab61eca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153045ab61eca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2489236282","title":"心脉医疗：终端调价等影响带来阶段扰动 股权激励目标彰显增长信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2489236282","media":"海通证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489236282?lang=zh_cn&edition=full","pubTime":"2024-12-06 00:00","pubTimestamp":1733414400,"startTime":"0","endTime":"0","summary":"此次员工持股计划业绩目标要求公司2025 年净利润不低于6 亿元，2025-2026年净利润累计值不低于13.2 亿元，2025-2027 年净利润累计值不低于21.84亿元，对应每年约20%的净利润增速。经公司测算，预计此次员工持股计划首次授予部分费用摊销在24-27 年分别为116.46 万元、2723.33 万元、1048.13 万元、412.08 万元。主动脉支架受终端调价等影响，24H2 业绩阶段性扰动。公司腹主动脉覆膜支架产品终端价格调整降价幅度20%左右至35%左右。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206164345ab62161f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206164345ab62161f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2489464751","title":"粗心致补税数千万的心脉医疗：拟推5折员工持股计划，给出盈利指引稳定军心","url":"https://stock-news.laohu8.com/highlight/detail?id=2489464751","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489464751?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:26","pubTimestamp":1733408798,"startTime":"0","endTime":"0","summary":"12月4日，心脉医疗发布公告，拟推2024年员工持股计划，每股购买价格58元，这较之当日收盘价101元/股，接近腰斩。随着本次员工持股计划的披露，似乎又一扫阴霾。根据员工持股计划公告，公司设定的业绩考核目标或给投资者们吃下了定心丸。根据公告，本次员工持股计划拟首次授予100万股，持有人总人数不超过187人，包括董事、监事、高级管理人员共7人，具体参加人数根据员工实际缴款情况确定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205222654ab5ffaf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205222654ab5ffaf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2489467817","title":"“忘填报表”痛失高企资格，心脉医疗面临6000万税款补缴","url":"https://stock-news.laohu8.com/highlight/detail?id=2489467817","media":"观察者网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489467817?lang=zh_cn&edition=full","pubTime":"2024-12-05 14:06","pubTimestamp":1733378769,"startTime":"0","endTime":"0","summary":"此消息一出，心脉医疗股价在公告发布后迅速反应，一度下跌超过6%，引发市场广泛关注。值得注意的事，此次事件是心脉医疗近期困境的延续。降价余波未平，高企资格再失，心脉医疗面临巨额税款补缴12月2日，心脉医疗在公告中详细说明了此次被取消高新技术企业资格的原因及后续处理措施。此次被取消高新技术企业资格，对心脉医疗的财务状况产生了不小的影响。心脉医疗表示，对通知书要求的税款及滞纳金，公司将予以补缴。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120514123798e58743&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120514123798e58743&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2489917175","title":"心脉医疗涨5% 推出员工持股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489917175","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489917175?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:30","pubTimestamp":1733362228,"startTime":"0","endTime":"0","summary":"12月05日，心脉医疗股价大幅上涨，截至09点30分，心脉医疗上涨5.25%，报106.30元/股，成交3502万元，换手率0.27%，振幅2.72%。资金动向截止发稿，心脉医疗获得主力净流入1265万元，其中超大单流入625万元，大单流入639万元。主营业务及业绩心脉医疗公司主营业务为主动脉及外周血管介入医疗器械的研发、生产和销售。最新财报显示，今年三季报，心脉医疗实现营业收入9.70亿元，同比增长9.13%，净利润为5.53亿元，同比增长42.46%，基本每股收益为4.49元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205093258ab5e60b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205093258ab5e60b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2488191767","title":"心脉医疗：拟推2024年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2488191767","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488191767?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:03","pubTimestamp":1733321021,"startTime":"0","endTime":"0","summary":"本员工持股计划拟持有的标的股票数量约110万股，约占本员工持股计划草案公布时公司股本总额12,326.2117万股的0.89%，具体股票数量将视回购情况而定。本员工持股计划实施后，公司全部有效的员工持股计划所持有的标的股票总数累计未超过公司股本总额的10%，单个持有人所持有的员工持股计划份额所对应的标的股票总数累计未超过公司股本总额的1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204220349abf5ba7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204220349abf5ba7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2488460199","title":"心脉医疗：12月3日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2488460199","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488460199?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:56","pubTimestamp":1733320608,"startTime":"0","endTime":"0","summary":"每经AI快讯，心脉医疗 12月4日晚间发布公告称，公司第三届第四次董事会会议于2024年12月3日在公司会议室以现场及通讯方式召开。审议了《关于提请股东大会授权董事会办理公司2024年员工持股计划相关事宜的议案》等。2023年1至12月份，心脉医疗的营业收入构成为：主动脉及外周血管用产品占比100.0%。心脉医疗的董事长是Jonathan Chen，男，49岁，学历背景为本科；总经理是朱清，男，43岁，学历背景为硕士。截至发稿，心脉医疗市值为124亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204215729a26c4d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204215729a26c4d16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2488999951","title":"心脉医疗(688016.SH)拟推2024年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2488999951","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488999951?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:53","pubTimestamp":1733320415,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心脉医疗(688016.SH)发布2024年员工持股计划(草案)，本员工持股计划初始设立时持有人总人数不超过187人(不含预留份额)，其中董事、监事、高级管理人员共7人，具体参加人数根据员工实际缴款情况确定。本员工持股计划拟持有的标的股票数量约110万股，约占本员工持股计划草案公布时公司股本总额的0.89%，具体股票数量将视回购情况而定。本员工持股计划购买公司回购专用账户内标的股票的价格为58元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688016"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","stockEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.0864},{"period":"3month","weight":0.5014},{"period":"6month","weight":0.1424},{"period":"1year","weight":0.0079},{"period":"ytd","weight":-0.0647}],"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","perCapita":"7634股","boardName":"专用设备制造业","registeredCapital":"12326万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":"　　上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来，一直深耕于主动脉及外周血管介入医疗器械领域，通过多年的经验积累，公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院，主动脉产品国内市场占有率已连续多年排名国产品牌第一。","serverTime":1734944623174,"listedPrice":46.23,"stockholders":"16145人(较上一季度增加10.30%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}